Rayonier Advanced Materials Inc. · NYSE:RYAM
Rayonier Advanced Materials — Southwest IDEAS Investor Conference 2025
16 slides from Rayonier Advanced Materials's conference presentation, Nov 19, 2025
Slide 1: Investor Presentation: Fourth Quarter Equity Conferences
Investor Presentation Fourth Quarter Equity Conferences November 2025
Slide 2: Safe Harbor
Safe Harbor Forward-Looking Statements Certain statements in this document regarding anticipated financial, business, legal or other outcomes, including business and market conditions, outlook and other similar statements relating to future events, developments or financial or operational performan
Slide 3: Non-GAAP Financial Measures
Non-GAAP Financial Measures This earnings release and the accompanying schedules contain certain non-GAAP financial measures, including EBITDA, adjusted EBITDA, adjusted free cash flows, adjusted income from continuing operations, adjusted net debt, and net secured debt. The Company believes these n
Slide 4: Who is RYAM
Who is RYAM ⎔ For nearly 100 years, RYAM has developed a platform that Cellulose Cellulose produces natural cellulose fibers that create value in a Specialties Commodities Biomaterials Paperboard High-Yield Pulp diverse range of end-use products o Acetate o Fluff o Biofuels o Kallima® brand o Mechan
Slide 5: RYAM Is Everywhere
RYAM Is Everywhere Food Personal Fluff Hygiene Ethers Pharmaceuticals Industrial Viscose/Lyocell Textiles Filter Lignin Acetate Plastic Biomaterials Bioethanol LCD/Film Bioenergy Tire Cord Packaging Casings Lottery Filtration Paperboard Other CS Commercial Nitrocellulose Print Microcrystalline Cellu
Slide 6: 2025: A Challenging Year
2025: A Challenging Year CLEAR PATH TO STRONG EBITDA AND CASH FLOW GROWTH IN 2026 AND BEYOND ($ Millions) 18 $215-235 20 10 ~$195 12 21 7 5 ~$135-140 2025 EBITDA Tariff FX Extraordinary Environmental PBD/HYP Economic 2025 Normalized Tariff PBD/HYP 2025 Original Guidance Impacts Operational (Non-cash
Slide 7: Tariffs, FX and Likely Tailwinds in 2026 Onwards
Tariffs, FX and Likely Tailwinds in 2026 Onwards 2025 tariff-related EBITDA headwind currently estimated at $27 million ⎔ The company expects that $7 million will be non-recurring based on current tariff policy ⎔ The recurring $20 million impact reflects indirect impacts on our customers and expecte
Slide 8: Objective: Strongly Grow Core EBITDA Over Next 2 Years
Objective: Strongly Grow Core EBITDA Over Next 2 Years ($ Millions) $50 $365 31 $315 89 30 50 ~$195 (80) (1) (1) (1) (1) 2025 Normalized CS Price Cost Cost Commodity Exposure Biomaterials 2027 Run-Rate AGE Project 2028 Run-Rate Core Business Increases Inflation Reduction Reduction Growth EBITDA (Cor
Slide 9: Compelling Industry Dynamics & Competitive Advantage
Compelling Industry Dynamics & Competitive Advantage RYAM is the leading global producer of Cellulose Specialties ⎔ Highly specialized, non-commodity products ⎔ Long customer qualification periods with high and risky switching costs ⎔ RYAM known for industry leading purity and product functionality,
Slide 10: RYAM's Cellulose Specialties Outlook
RYAM’s Cellulose Specialties Outlook Negotiations underway targeting a significant reset in 2026 pricing across Cellulose Specialties grades ⎔ We are targeting a significant pricing reset for 2026 beyond prior-year increases for our Cellulose Specialties products to reflect the value of our products
Slide 11: High Return Growth Opportunities in Biomaterials
High Return Growth Opportunities in Biomaterials Anatomy of a tree: ⎔ 50% of a tree is dry solids, made up of ~40% cellulose and ~60% other chemical compounds ⎔ RYAM’s biomaterials strategy focuses on monetizing the “other 60%”: – Biofuels/Bioelectricity – Lignosulfonates – SAF – Crude Tall Oil (CTO
Slide 12: Current High Return Biomaterials Projects
Current High Return Biomaterials Projects Altamaha Green Energy JV: Est. 12X RYAM equity ROI (1) ⎔ 70 MW renewable power; 30-year PPA with Georgia Power (RYAM 49%) ⎔ ~$100M+ JV EBITDA annually, 80%+ margin; ~$500M total capex, RYAM cash equity $46M; RYAM proportional EBITDA expected to exceed $50M ⎔
Slide 13: Ability to Recycle Capital at Attractive ROI
Ability to Recycle Capital at Attractive ROI ⎔ RYAM opportunity to generate strong ROI is driven by its ability to leverage its extensive and unique asset base – This footprint enables low-cost expansion into complementary Biomaterials projects – Illustratively, RYAM’s Jesup plant alone has an estim
Slide 14: Solid Balance Sheet and Liquidity
Solid Balance Sheet and Liquidity RYAM maintains a balance sheet sufficient to fund key growth initiatives without shareholder dilution ⎔ $140 million of global liquidity including $77 million of cash ⎔ Net secured leverage ratio of 4.1x covenant EBITDA, well within the 5.0x covenant threshold ⎔ $40
Slide 15: RYAM's Compelling Investment Thesis
RYAM’s Compelling Investment Thesis WE BELIEVE RYAM’S CURRENT STOCK PRICE DOES NOT FULLY REFLECT THE INTRINSIC VALUE OF ITS ASSETS OR THE EARNINGS POTENTIAL FROM ITS GROWTH STRATEGY The short term, isolated issues that impacted RYAM are largely behind us ⎔ Direct tariff impacts have stabilized; cont
Slide 16: Thank You
Thank You
Rayonier Advanced Materials — Southwest IDEAS Investor Conference 2025 on 6ix